Cleared Traditional

K082315 - EC50 MICRO+ SMOKERLYZER

K082315 is an FDA 510(k) clearance for EC50 MICRO+ SMOKERLYZER, manufactured by Bedfont Scientific, Ltd.. The device is a Class 2 Toxicology device with product code CCJ cleared through the Traditional 510(k) pathway after a 537-day FDA review.

K082315 · Bedfont Scientific, Ltd. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2010
Decision
537d
Days
Class 2
Risk

K082315 is an FDA 510(k) clearance for the EC50 MICRO+ SMOKERLYZER. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Bedfont Scientific, Ltd. (Rochester, Kent, GB). The FDA issued a Cleared decision on February 1, 2010 after a review of 537 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 868.1430 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Toxicology submissions.

View all Bedfont Scientific, Ltd. devices

FDA 510(k) Submission Details - K082315

510(k) Number K082315 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2008
Decision Date February 01, 2010
Days to Decision 537 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
450d slower than avg
Panel avg: 87d · This submission: 537d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCJ Device Classification - Class 2, Special Controls

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 22
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K082315.
CoSense ETCO Monitor
K151107 · Capnia, Inc. · Jul 2015
COSENSE CO MONITOR
K130036 · Capnia, Inc. · Jan 2014
COSENSE
K121768 · Capnia, Inc. · Oct 2012
TABATABA COTESTER
K080278 · Fim Medical · Nov 2008
EC50 TOXCO+ BREATH CARBON MONOXIDE MONITOR
K070259 · Bedfont Scientific, Ltd. · Feb 2008
PICO SMOKERLYZER, MODEL EC-50
K000962 · Bedfont Scientific, Ltd. · Apr 2000